Moreover, recent evidence indicates that MET signaling participates in the acquirement of mesenchymal phenotype, tumor plasticity and adaptive responses to metabolic stress, contributing to the recurrence and metastatic dissemination of cancer cells [144,145]. This evidence concerns the gene MET and cancer.